Byrne, B. J., Bratkovic, D., Laforet, P., Mozaffar, T., van der Ploeg, A., Roberts, M., … Kishnani, P. S. (2021). EFFICACY AND SAFETY OF CIPAGLUCOSIDASE ALFA/MIGLUSTAT VERSUS ALGLUCOSIDASE ALFA/PLACEBO IN LATE-ONSET POMPE DISEASE: A PHASE 3 TRIAL (PROPEL). In MUSCLE & NERVE (Vol. 64, pp. S64–S65).

Byrne, Barry J., Drago Bratkovic, Pascal Laforet, Tahseen Mozaffar, Ans van der Ploeg, Mark Roberts, Benedikt Schoser, et al. “EFFICACY AND SAFETY OF CIPAGLUCOSIDASE ALFA/MIGLUSTAT VERSUS ALGLUCOSIDASE ALFA/PLACEBO IN LATE-ONSET POMPE DISEASE: A PHASE 3 TRIAL (PROPEL).” In MUSCLE & NERVE, 64:S64–65, 2021.

Byrne BJ, Bratkovic D, Laforet P, Mozaffar T, van der Ploeg A, Roberts M, et al. EFFICACY AND SAFETY OF CIPAGLUCOSIDASE ALFA/MIGLUSTAT VERSUS ALGLUCOSIDASE ALFA/PLACEBO IN LATE-ONSET POMPE DISEASE: A PHASE 3 TRIAL (PROPEL). In: MUSCLE & NERVE. 2021. p. S64–5.

Byrne, Barry J., et al. “EFFICACY AND SAFETY OF CIPAGLUCOSIDASE ALFA/MIGLUSTAT VERSUS ALGLUCOSIDASE ALFA/PLACEBO IN LATE-ONSET POMPE DISEASE: A PHASE 3 TRIAL (PROPEL).” MUSCLE & NERVE, vol. 64, 2021, pp. S64–65.

Byrne BJ, Bratkovic D, Laforet P, Mozaffar T, van der Ploeg A, Roberts M, Schoser B, Toscano A, Jiang H, Sitaraman S, Kuchipudi S, Kazi Z, Goldman M, Castelli J, Kishnani PS. EFFICACY AND SAFETY OF CIPAGLUCOSIDASE ALFA/MIGLUSTAT VERSUS ALGLUCOSIDASE ALFA/PLACEBO IN LATE-ONSET POMPE DISEASE: A PHASE 3 TRIAL (PROPEL). MUSCLE & NERVE. 2021. p. S64–S65.